Success Metrics

Clinical Success Rate
81.8%

Based on 9 completed trials

Completion Rate
82%(9/11)
Active Trials
1(7%)
Results Posted
22%(2 trials)
Terminated
2(14%)

Phase Distribution

Ph phase_3
2
14%
Ph phase_4
3
21%
Ph phase_2
3
21%
Ph phase_1
1
7%
Ph not_applicable
4
29%
Ph early_phase_1
1
7%

Phase Distribution

2

Early Stage

3

Mid Stage

5

Late Stage

Phase Distribution14 total trials
Early Phase 1First-in-human
1(7.1%)
Phase 1Safety & dosage
1(7.1%)
Phase 2Efficacy & side effects
3(21.4%)
Phase 3Large-scale testing
2(14.3%)
Phase 4Post-market surveillance
3(21.4%)
N/ANon-phased studies
4(28.6%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

81.8%

9 of 11 finished

Non-Completion Rate

18.2%

2 ended early

Currently Active

1

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(9)
Terminated(2)
Other(2)

Detailed Status

Completed9
Terminated2
unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
1
Success Rate
81.8%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (7.1%)
Phase 11 (7.1%)
Phase 23 (21.4%)
Phase 32 (14.3%)
Phase 43 (21.4%)
N/A4 (28.6%)

Trials by Status

recruiting17%
terminated214%
completed964%
unknown214%

Recent Activity

Clinical Trials (14)

Showing 14 of 14 trials
NCT06287619Phase 2

Post-operative Intravenous Iron to Treat Iron-deficiency Anemia in Patients Undergoing Cardiac Surgery

Recruiting
NCT06319144Not Applicable

Effect of Intravenous 5% Dextrose Infusion During Recovery from Anesthesia on the Quality of Early Postoperative Recovery in Patients Undergoing Painless Gastrointestinal Endoscopy

Completed
NCT02967172Phase 4

Efficacy of Multimodal Periarticular Injections in Operatively Treated Ankle Fractures

Completed
NCT06008223Not Applicable

Clinical Analysis of Vitamin B6 in Sepsis

Completed
NCT05812014Phase 3

Clinical Trail of SARS-CoV-2 Bivalent mRNA Vaccine (LVRNA021) in Participants Aged 18 Years and Older

Unknown
NCT05188417Phase 2

A Study Evaluating the Safety and Efficacy of Tirofiban in Combination With Alteplase in Acute Ischemic Stroke

Unknown
NCT03787368Phase 1

End-stage Renal Disease (ESRD) Pilot Study

Completed
NCT02895373Phase 2

PGE1 as Additive Anticoagulant in ECMO-Therapy

Terminated
NCT03191201Phase 4

A Double Blind Randomised Placebo-controlled Trial to Assess the Role of Iron Repletion in Glucose Homeostasis.

Terminated
NCT02793947Phase 4

Efficacy of Peri-Incisional Multimodal Drug Injection Following Operative Management of Femur Fractures

Completed
NCT02506894Early Phase 1

Fetal Middle Cerebral Artery Doppler in Preterm Births Receiving Magnesium Sulfate for Neuroprotection

Completed
NCT02462902Not Applicable

Comparison And Outcomes Of Fluid Resucitation With 0.9% Normal Saline And 5% Albumin In Cirrhosis Patients With Sepsis Induced Hypotension

Completed
NCT00508495Phase 3

Analgesic Efficacy, Safety and Tolerability of Two Paracetamol-Containing Solutions in Post-Surgical Hip Replacement Pain

Completed
NCT01363414Not Applicable

Sodium Hyaluronate and Wavefront Aberrations in Dry Eyes

Completed

All 14 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
14